Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy

Kim, DW; Talati, C; Kim, R

Kim, R (reprint author), H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, 12902 Magnolia Dr,FOB 2, Tampa, FL 33612 USA.

JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017; 8 (2): 256

Abstract

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with poor prognosis. The incidence of HCC and HCC-related deaths have increased......

Full Text Link